• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS 0.00% 28.0¢

VECTUS BIOSYSTEMS LIMITED

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VBS 23/02/24 0 159
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  159 
VBS 06/02/24 1 382
06/02/24 Last post  MoneyGrinch Comments Created with Sketch.  1  Views Created with Sketch.  382 
VBS 06/12/23 0 280
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
06/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  280 
VBS 06/12/23 0 146
06/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  146 
VBS 04/12/23 0 179
04/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  179 
VBS 04/12/23 0 114
04/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  114 
VBS 04/12/23 0 183
04/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  183 
VBS 22/11/23 0 136
22/11/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  136 

See All Discussions arrow Created with Sketch.

Timeline

Half Year Report & Appendix 4D
23 Feb 16:14
 
Quarterly Activities & Appendix 4C Cash Flow Reports
31 Jan 15:54
 
Change in substantial holding
06 Dec 16:48
 
Change of Director's Interest Notice - KD
06 Dec 13:41
 
Issue of Shares - KD
04 Dec 17:10
 
Application for quotation of securities - VBS
04 Dec 16:58
 
View More arrow Created with Sketch.
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $14.89M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 35000 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 387 1
View Market Depth
Last trade - 16.12pm 19/03/2024 (20 minute delay) ?
VBS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.